Kaila Stipancic

PhD, CCC-SLP

Kaila Stipancic.

Kaila Stipancic

PhD, CCC-SLP

Kaila Stipancic

PhD, CCC-SLP

Certifications

  • American Speech-Language-Hearing Association Certificate of Clinical Competence - Speech-Language Pathology

Research Area

Broadly, Prof. Stipancic studies how the brain controls the muscles of speech and swallowing and the perceptual, acoustic, kinematic, and neurophysiologic consequences of neurodegenerative disease on these functions. She has particular interest in the measurement of relevant clinical outcomes, such as speech intelligibility, and in improving therapeutic options to improve the quality of life of patients with oromotor impairments. 

Awards and Honors

  • American Speech-Language-Hearing Association, Lessons for Success Fellow, 2023
  • American Speech-Language-Hearing Foundation New Investigator's Research Grant, 2023
  • Acoustical Society of America Raymond H. Stetson Scholarship in Phonetics and Speech Science

Selected Publications or Presentations

  • Stipancic, K. L., Golzy, M., Zhao, Y., Pinkerton, L., Rohl, A., & Kuruvilla-Dugdale, M. (2023). Improving perceptual speech ratings: The effects of auditory training on judgments of dysarthric speech. Journal of Speech, Language, and Hearing Research, 66(11), 4236-4258. doi: 10.1044/2023_JSLHR-23-00322
  • Stipancic, K. L., Wilding, G., & Tjaden, K. (2023). Lexical characteristics of the Speech Intelligibility Test: Effects on transcription intelligibility for speakers with multiple sclerosis and Parkinson’s disease. Journal of Speech, Language, and  Hearing Research; Special Issues from the 2022 Conference on Motor Speech, 66(8S), 3115-3131. doi: 10.1044/2023_JSLHR-22-00279
  • Stipancic, K. L., van Brenk, F., Kain, A., Wilding, G., & Tjaden, K. (2022). Clear speech variants: An investigation of intelligibility and speaker effort in speakers with Parkinson’s disease. American Journal of Speech-Language Pathology, 31(6), 2789-2805. doi: 10.1044/2022_AJSLP-22-00189
  • Stipancic, K. L., & Tjaden, K. (2022). Minimally detectable change of speech intelligibility in speakers with multiple sclerosis and Parkinson’s disease. Journal of Speech, Language, and Hearing Research, 65(5), 1858-1866. doi: 10.1044/2022_JSLHR-21-00648
  • Stipancic, K. L., Palmer, K., Rowe, H. P., Yunusova, Y., Berry, J. D., & Green, J. R. (2021). ‘You say severe, I say mild’: Toward an empirical classification of dysarthria severity. Journal of Speech, Language, and Hearing Research, 64(12), 4718-4735. doi: 10.1044/2021_JSLHR-21-00197
  • Stipancic, K. L., Kuo, Y., Miller, A., Ventresca, H. M., Sternad, D., Kimberley, T. J., & Green, J. R. (2021). The effects of sustained oromotor activity on speech motor learning: Speech biomechanics and neurophysiologic correlates. Experimental Brain Research, 239, 3487-3505. doi: 10.1007/s00221-021-06206-5
  • Stipancic, K. L., Yunusova, Y., Berry, J. D., & Green, J. R. (2018). Minimally detectable change and minimal clinically important difference of a decline in sentence intelligibility and speaking rate for individuals with ALS. Journal of Speech, Language, and Hearing Research, 61(11), 2757-2771. doi: 10.1044/2018_JSLHR-S-17-0366
  • Stipancic, K. L., Tjaden, K., & Wilding, G. (2016). Comparison of intelligibility measures for adults with Parkinson’s disease, adults with multiple sclerosis, and healthy controls. Journal of Speech, Language, and Hearing Research, 59(2), 230-238. doi: 10.1044/2015_JSLHR-S-15-0271

For a list of all publications, see Google Scholar profile.

Current Courses

  • CDS 575: Dysphagia
  • CDS 640: Motor Speech Disorders
  • CDS 491/687: Special Topics, Evidence-Based Practice